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Objective: The study aimed at exploring bereavement and complicated grief (CG) symptoms 
among subjects without a history of coronary heart disease (CHD) at the time of a first acute 
coronary syndrome (ACS) and to evaluate the relationship of CG symptoms and ACS.
Method: Overall, 149 subjects with ACS (namely, acute myocardial infarct with or without 
ST-segment elevation or unstable angina), with no previous history of CHD, admitted to three 
cardiac intensive care units were included and evaluated by the Structured Clinical Interview 
for Complicated Grief (SCI-CG), Hamilton Depression Rating Scale, Hamilton Anxiety Rating 
Scale, and the 36-item Short-Form Health Survey (MOS-SF-36).
Results: Of the total sample of 149 subjects with ACS, 118 (79.2%) met criteria for DSM-5 
persistent complex bereavement disorder. Among these, subjects who lost a partner, child, or 
sibling were older (P=0.008), less likely to be working (P=0.032), and more likely to be suffering 
from hypertension (P=0.021), returned higher scores on the SCI-CG (P=0.001) and developed 
the index ACS more frequently between 12 and 48 months after the death than those who lost a 
parent or another relative (P#0.0001). The occurrence of ACS 12–48 months (P=0.019) after the 
loss was positively correlated with SCI-CG scores. An inverse relationship with SCI-CG scores 
was observed for patients who experienced ACS more than 48 months after the loss (P=0.005). 
The SCI-CG scores significantly predicted lower scores on the “general health” domain of MOS-
SF-36 (P=0.030), as well as lower scores on “emotional well-being” domain (P=0.010).
Conclusion: A great proportion of subjects with ACS report the loss of a loved one. Among 
these, the loss of a close relative and the severity of CG symptoms are associated with poorer 
health status. Our data corroborate previous data indicating a strong relationship between CG 
symptoms and severe cardiac problems.
Keywords: acute coronary syndrome (ACS), coronary heart disease (CHD), CG symptoms, 
complicated grief, DSM-5
Introduction
A growing body of data indicates that 10%–20% of bereaved persons develop a form 
of inordinate, prolonged grief, variously referred to as complicated grief (CG), pro-
longed grief disorder, or traumatic grief and it is included among “disorders requiring 
further research” in Diagnostic and Statistical Manual of Mental Disorders, 5th edition 
(DSM-5) under the name of Persistent Complex Bereavement Disorder.1–4
Symptoms of CG include yearning and longing for the deceased, with intense 
sorrow and painful emotions persisting more than 1 year after the loss. Patients show 
preoccupation with the deceased and with the circumstances of the death and may have 
recurrent, intrusive images or thoughts of the death, may feel a sense of disbelief and 
may avoid reminders of the deceased. In addition, subjects with CG may feel that life 
is meaningless or empty without the deceased and they may desire to die in order to 
be reunited with the deceased.5–10
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Several studies suggest that CG impacts uniquely on 
physical and mental health, increasing the risk for suicidal 
ideation, substance abuse, chronic medical conditions, and 
impaired global functioning.11–17 Specifically, an association 
between CG symptoms and the risk of developing cardiac 
problems has been suggested.11 However, to the best of our 
knowledge, only one study evaluated CG symptoms among 
subjects with heart diseases. In this report, poorer physical 
and mental health outcomes were found among patients who 
had undergone coronary artery bypass grafts with concurrent 
CG compared to those without CG.18
The purpose of this study is to investigate bereavement 
among inpatients admitted for an acute coronary syndrome 
(ACS) with no previous history of coronary heart disease 
(CHD) and to evaluate whether symptoms of CG may have 
an impact on ACS outcomes and/or physical and mental 
health-related quality of life.
Methods
sample
Patients with ACS and no previous history of CHD who were 
admitted to three cardiac intensive care units (CICUs) were 
eligible for inclusion if they met the criteria for either acute 
myocardial infarct with ST-segment elevation or without 
ST-segment elevation or unstable angina, verified by stan-
dard ACS criteria. Additional details about study sample and 
methods have been published elsewhere.19,20
The three units were located in a northwest area of 
Italy, with an average distance of 40 miles from each other 
and serving similar geographic catchment areas in terms 
of sociodemographic characteristics. Exclusion criteria 
were the presence of neoplastic disease, severe pulmonary, 
hepatic, or renal insufficiency, infections requiring antibi-
otics, autoimmune disease, immunosuppressive therapy, 
severe anemia, and severe degenerative disease of the 
central nervous system. The study protocol was approved, 
according to Declaration of Helsinki, by the University of 
Pisa and ASL-5 ethics committees, and written informed 
consent was obtained from all patients.
cardiological evaluation
Data on patients’ demographics, medical history, clinical 
characteristics, electrocardiographic findings, ACS definition 
and treatment interventions, as well as in-hospital outcomes 
were reported in a detailed standardized case record form, 
adapted from the Blitz study,20 by a trained cardiologist in 
each CICU. The details on symptoms onset, first medical help 
seeking, and arrival at hospital CICU were collected as soon 
as patients could be interviewed. Particular care was taken in 
assessing the timing of arrival at hospital CICU, ECG execu-
tion, and reperfusion treatment. Additional items included 
length of stay in the CICU and overall hospital stay, timing 
of invasive procedures, and transfer to a tertiary care hospital 
to undergo coronary angiography and/or revascularization.
risk factors evaluation
All subjects were assessed at the time of enrollment for the 
following measures: resting blood pressure and cardiovascu-
lar risk factors, including tobacco smoking, diabetes mellitus, 
and hypertension. Hypertension was defined as either resting 
systolic or diastolic blood pressure greater than or equal to 
140/90 mmHg at two different times or being on antihyper-
tensive medications. Diabetes mellitus was defined as a serum 
fasting glucose level greater than or equal to 7.1 mmol/L or 
being on hypoglycemic medications.
Psychiatric assessment
The severity of CG symptoms was investigated by the Struc-
tured Clinical Interview for Complicated Grief (SCI-CG), 
a 33-item semi-structured interview assessing the presence or 
absence of symptoms associated with CG, as well as details 
surrounding the death of a loved one.21,22
The presence and severity of current depression were 
assessed by the 17-item Hamilton Depression Rating Scale 
(HAM-D).23 The HAM-D provides an indication of depres-
sion and, over time, a guide to recovery. It is widely used 
to provide accepted outcome measures for evaluating the 
severity of depression symptoms in ACS patients. Eight items 
are scored on a 5-point scale, ranging from 0= not present to 
4= severe. Nine items are scored from 0 to 2. Scores of 5 or 
below define the absence of clinically relevant depression; 
scores between 6 and 13 indicate mild depression; scores 
from 14 to 18 indicate moderate depression; and scores of 
19 and above indicate severe depression.24
The severity of anxiety symptoms was evaluated by 
means of the Hamilton Anxiety Rating Scale (HAM-A).25 
The scale comprises 14 items, exploring both psychic and 
somatic anxiety. Each item is scored on a 5-point scale, rang-
ing from 0 (not present) to 4 (severe), where a total score 
below 17 indicates mild anxiety, a score between 18 and 24 
indicates mild-to-moderate anxiety, and scores from 25 and 
above indicate moderate-to-severe anxiety.
The 36-item Short-Form Health Survey (MOS-SF-36)26 
was used to assess general health status. The measure 
comprises 36 items within the following eight subscales: 
“physical functioning” (extent to which health limits physical 




complicated grief and acute coronary syndromes
activities), “role physical” (extent to which physical health 
interferes with work or other daily activities), “bodily pain” 
(intensity of pain and effect on normal work), “general 
health” (personal evaluation of health, current and outlook), 
“vitality” (feeling energetic), “social functioning” (extent to 
which physical health or emotional problems interfere with 
normal social activities), “role emotional” (extent to which 
emotional problems interfere with work or other daily activi-
ties), and “mental health” (general mental health, including 
depression, anxiety, behavioral and emotional control, gen-
eral positive affect). The first four subscales comprise the 
physical component summary score, while the other four 
subscales comprise the mental component summary score. 
Subscale raw scores are standardized and range between 
0 and 100, where 0 is the worst and 100 the best possible 
health status.27
statistical analyses
Significant differences between subjects who lost a parent/a 
sibling/a partner and those who lost another relative were 
evaluated by two-tailed t-tests for continuous measures and 
by χ2-tests for categorical variables.
In order to evaluate the health consequences associated 
with CG, SCI-CG scores were used to predict the various 
health outcomes. Continuous outcomes (ie, age at index 
ACS, the number of days spent in the CICU, and MOS-SF-36 
domain scores) were analyzed using a series of multiple 
regressions. In each of these analyses, health outcomes were 
regressed on the SCI-CG score while controlling for age, sex, 
and cardiovascular risk factors (tobacco smoking, diabetes 
mellitus, and hypertension).
Dichotomous dependent variables (eg, presence/absence 
of single ACS risk factors) were analyzed by a series of 
logistic regressions. Each model estimated the effects of 
SCI-CG score on a single dichotomous health outcome while 
controlling for age, sex, and cardiovascular risk factors.
Comparisons were considered statistically significant 
at the 0.05 level (P#0.05). Analyses were conducted 
using SPSS, version 20 (IBM Corporation, Armonk, NY, 
USA).28
Results
Overall, 149 subjects with ACS and with no previous his-
tory of CHD were recruited. Among them, 118 (79.2%) had 
experienced the death of a loved one and met the criteria for 
DSM-5 persistent complex bereavement disorder. The 118 
bereaved included in the analyses did not differ from the rest 
of total group in terms of sex, age, CHD risk factors, HAM-D, 
HAM-A, SCI-CG total scores, or MOS-SF-36 domain scores 
(data not shown here).
Demographical and clinical characteristics of bereaved 
subjects dichotomized by relationship to the deceased 
(partner/child/sibling vs parent/other relatives) are shown 
in Table 1.
Subjects who lost a partner, a child, or a sibling were 
older (P=0.008) and less likely to be working (P=0.032) 
than those without such losses. They showed significantly 
greater scores on the SCI-CG (P=0.001) and were more 
likely to have developed the index ACS between 12 and 
48 months after the death than those who lost a parent or 
another relative (P#0.0001). The two groups did not differ 
on outcomes of current ACS. However, subjects who lost a 
partner, a child, or a sibling were more likely to have been 
diagnosed with hypertension (P=0.021) than those who lost 
a parent or another relative.
Table 2 demonstrates linear and logistic regression mod-
els in which SCI-CG score served as predictor of various 
clinical correlates in the overall sample of bereaved subjects 
with ACSs.
Controlling for age, sex, and CHD risk factors, mean 
SCI-CG scores were correlated with the occurrence of the 
ACS between 12 and 48 months (P=0.019) and inversely cor-
related with the onset of the ACS more than 48 months after 
the loss (P=0.005). Moreover, SCI-CG scores significantly 
predicted lower scores on the “general health” domain of 
MOS-SF-36 (P=0.030), as well as lower scores on “emo-
tional well-being” domain (P=0.010) controlling for age, 
sex, HAM-D and HAM-A scores.
Discussion
This study aimed at exploring bereavement and CG symp-
toms among subjects with no history of CHD at the time of 
a first ACS and at evaluating the impact of CG symptoms on 
ACS correlates and health status. We found that the majority 
(79.2%) of individuals with a recent ACS had experienced 
the death of a loved one and had presented symptoms of 
persistent complex bereavement disorder. Interestingly, 
while bereavement itself was not associated with specific 
sociodemographic and clinical characteristics, some differ-
ences emerged with respect to association between the loss 
and some clinical variables preceding ACS. In fact, the loss 
of a close relative (namely, a partner, a child, or a sibling) 
was associated with the presence of hypertension and with 
worse health status with respect to the loss of a parent or 
other relative. Moreover, while the majority of subjects, 
independently from the relationship to the deceased, had 





developed the index ACS more than 48 months after the 
death, a significantly higher proportion (approximately one 
in five) of individuals who lost a close relative had developed 
the index ACS between 12 and 48 months after the death. 
In addition, they had higher levels of CG symptoms than 
subjects who lost a parent or other relative. The fact that 
that the nature and quality of the relationship between the 
subjects and their deceased relative were not measured limits 
the interpretation of these associations. However, the find-
ing of higher levels of CG among closely related people as 
partner, siblings, and children is consistent with several data 
from the literature. The loss of a child is among the most 
distressing experiences in life.29,30 Bereaved parents have 
been recently found to have more severe CG than those who 
have suffered another loss.22 In two previous investigations 
conducted in the general population, the loss of a spouse or a 
child was shown to heighten the risk of developing CG.31,32 
Moreover, in another population-based study of bereaved 
adults who had lost a brother or a sister to cancer, the major-
ity of subjects had not worked through their grief over the 
sibling’s death after 2–9 years.33
Another important finding is that, in the overall sample of 
bereaved subjects, after controlling for effect of age, sex, and 
ACS risk factors, severity of CG symptoms was positively 
correlated with the occurrence of the ACS between 12 and 
48 months, and inversely correlated with the occurrence of 
the ACS later than 48 months after the death of a closely 
related person.
Our results are commensurate to those of Ghesquiere 
et al18 the only previous study, to our knowledge, to examine 
CG in a population with coronary artery disease. The authors 
found that 90% of depressed participants had experienced 
the death of a loved one. A positive CG-screen was associ-
ated with more severe depression, poorer mental health 
related quality of life, lower social support, higher tobacco 
use, increased use of antidepressant medication, and poorer 
disease-specific physical functioning. Adding to previ-
ous longitudinal data showing that CG symptoms might 
be chrono logically related to the development of cardiac 
problems,11 our findings seem to indicate a “time frame” in 
which the severity of CG is more likely to be associated to 
the index ACS. Interestingly, 12 months is precisely the 
Table 1 Demographic and clinical characteristics of 118 individuals with no previous history of chD admitted for index acs to three 
cicUs dichotomized by relationship to the deceased





agec 64.1 (9.4) 57.7 (9.8) -2.690 0.008
Female sexb 4 (17.4) 17 (17.9) – 1
Years of educationc 9.5 (4.3) 10.9 (3.7) 1.458 0.148
Working 9 (39.1) 62 (65.3) 5.277 0.032
Time between death and acs ,12 monthsa,b 1 (4.3) 8 (8.4) – 0.686
12–48 monthsa,b 5 (21.7) 3 (3.2) – 0.007
More than 48 monthsa,b 17 (73.9) 83 (87.4) – 0.100
sci-cg scorec 47.7 (13.9) 35.7 (6.9) -3.978 0.001
haM-D scorec 5.3 (4.3) 4.9 (5.0) -0.539 0.591
haM-a scorec 5.8 (4.0) 5.1 (5.0) -0.615 0.540
Diabetesb 6 (26.1) 11 (11.6) 3.161 0.097
smokingb 14 (4.3) 56 (55.8) 0.013 1
hypertensionb 17 (73.9) 44 (46.3) 5.648 0.021
sTeMib 16 (69.6) 63 (66.3) 0.010 1
NsTeMib 7 (30.4) 24 (25.3) 0.177 0.793
Unstable anginab 0 (0) 5 (5.3) – 0.581
Days spent in the cicUc 3.8 (2.6) 5.4 (5.4) 1.351 0.179
sF-36 physical functioning 45.0 (41.2) 46.9 (32.9) 0.205 0.839
role physicalc 64.1 (46.1) 75.3 (41.6) -0.845 0.400
role emotionalc 64.1 (46.1) 75.3 (41.6) 0.855 0.396
energy–fatiguec 52.6 (15.6) 58.8 (17.0) 1.582 0.116
emotional well-beingc 60.9 (15.6) 66.9 (17.2) 1.523 0.130
social functioningc 64.7 (27.1) 71.4 (27.5) 1.064 0.289
Painc 78.3 (19.9) 71.5 (23.9) -1.260 0.210
general healthc 51.0 (19.6) 57.8 (16.4) 1.709 0.090
Notes: aFisher’s exact test; bN (%); cMean (standard deviation).
Abbreviations: chD, coronary heart disease; acs, acute coronary syndrome; cicU, cardiac intensive care unit; sci-cg, structured clinical interview for complicated grief; 
haM-D, hamilton depression rating scale; haM-a, hamilton anxiety rating scale; sTeMi, with sT-segment elevation; NsTeMi, without sT-segment elevation.
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time lapse that discriminates normal grief from persistent 
grief. In fact, in the DSM-5, persistent complex bereavement 
disorder is diagnosed only if at least 12 months (6 months 
in children) have elapsed since the death of someone with 
whom the bereaved had a close relationship (Criterion A).4 
Within this framework, our data suggest that the severity of 
pathological reaction rather than physiological grief symp-
toms could have an impact on facilitating the onset of the 
ACS. Finally, the severity of CG symptoms was found to 
be significantly associated to poor health status, as evalu-
ated by the MOS-SF-36. The association was significant for 
emotional well-being, after controlling for both anxiety and 
depressive symptom severity. This finding corroborates pre-
vious data indicating that CG, despite being highly comorbid 
with depression, may impact on quality of life independently 
of concomitant depressive symptoms.9,34–36 It is also note-
worthy that CG symptoms demonstrated a negative impact 
on MOS-SF-36 “general health,” even when the presence of 
diabetes and hypertension were controlled for.
Several limitations need to be acknowledged in presenting 
our findings. First, we included subjects with no previous 
history of CHD and who were hospitalized at their first 
ACS, which may reduce the generalizability of our results. 
Second, the study sample was relatively small, with a small 
number of patients in the group of subjects who lost a close 
relative; thus, some comparisons with respect to kinship 
to the deceased may have been significant with a larger 
sample. Notwithstanding, it should also be kept in mind 
that psychiatric assessments of ACS patients, especially in 
relation to loss events, is not straightforward because of the 
patient’s objective physical status. It is possible that there 
was not sufficient power to detect meaningful impacts of 
CG symptoms on some health variables. For example, a 
previous study found a strong correlation between CG and 
increased consequent tobacco smoking,37 an association 
that we failed to find in our study. Analogously, potential 
limited power imposes cautiousness in interpreting results 
of regression analyses, where multiple suitable explanatory 
Table 2 Unstandardized regression coefficients and ORs for predictors of mental and physical health outcomes for bereaved persons 
with index acs
Dependent variable Independent variable: SCI-CG score
Model parameter estimates
B SE OR 95% CI Goodness 
of fit (χ2/R2)
Significance
Diabetesa -0.014 0.033 0.99 0.93–1.05 1.606b 0.682
smokinga 0.040 0.025 1.04 0.99–1.09 16.266b 0.112
hypertensiona 0.005 0.022 1.01 0.96–1.05 14.723b 0.817
aPaa -0.030 0.037 0.97 0.90–1.04 1.771b 0.412
Beta-blockersa -0.013 0.035 0.99 0.92–1.06 0.210b 0.704
ace-inibitorsa -0.004 0.028 0.99 0.94–1.05 7.928b 0.881
statinsa -0.006 0.038 0.99 0.92–1.07 5.385b 0.867
Time between death and acsc
less than 12 monthsc 0.025 0.034 1.03 0.96–1.10 4.863b 0.457
Between 12 and 48 monthsc 0.145 0.062 1.16 1.02–1.31 10.249b 0.019
More than 48 monthsc -0.084 0.030 0.92 0.87–0.98 10.872b 0.005
age at index acsd 0.102 0.104 – – 0.022e 0.331
Days spent in the cicUf -0.035 0.054 – – 0.072e 0.521
sF-36 physical functioningf 0.044 0.350 – – 0.086e 0.901
role physicalf -0.692 0.403 – – 0.044e 0.088
role emotionalg -0.567 0.532 – – 0.267e 0.291
energy–fatigueg -0.263 0.156 – – 0.286e 0.094
emotional well-beingg -0.345 0.132 – – 0.500e 0.010
social functioningg -0.211 0.254 – – 0.280e 0.408
Painh -0.017 0.241 – – 0.072e 0.093
general healthh -0.389 0.177 – – 0.074e 0.030
Notes: asci-cg score, age, sex simultaneously entered as independent variables in the linear regression model. bχ2 values. csci-cg score, age, sex, antihypertensive 
treatment simultaneously entered as independent variables in the linear regression model. dsci-cg score, age, sex, smoking, beta-blockers use, simultaneously entered as 
independent variables in the linear regression model. eR2 values. fsci-cg score, hypertension, diabetes, age, sex, simultaneously entered as independent variables in the linear 
regression model. gsci-cg score, haM-D, haM-a, age, sex, simultaneously entered as independent variables in the linear regression model. hsci-cg score, hypertension, 
smoking, diabetes, sex, simultaneously entered as independent variables in the linear regression model.
Abbreviations: se, standard error of mean; Ors, odds ratios; acs, acute coronary syndrome; aPa, anti platelet agent; sci-cg, structured clinical interview for complicated 
grief; cicU, cardiac intensive care unit; haM-D, hamilton depression rating scale; haM-a, hamilton anxiety rating scale.





variables were used. Third, although depression and anxiety 
symptoms were investigated, the study lacked a complete 
psychiatric evaluation, thus our findings could also be related 
to other, unmeasured confounders, such as other concurrent 
mental disorders.
Our data suggest a temporal relationship between CG 
and the occurrence of the first acute coronary episode. 
The differential temporal effect of grief in our sample (ie, 
12–48 months vs .48 months) stimulates further research to 
develop preventive interventions for cardiovascular patients 
and investigate potential effects of CG on endothelial/
vascular parameters connected to occurrence of ACSs.
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